HMGB1 and prostate cancer: HMGB1-driven JNK and ERK activation in leukemia and colorectal cancer reinforces this autophagy-dependent apoptotic escape [67,124], while an HMGB1/c-Myc circuit mediates paclitaxel resistance in castration-resistant prostate cancer [125] (Figure 3).